scout
Opinion|Videos|May 3, 2024

LITESPARK-005: Belzutifan in Previously Treated Advanced Clear Cell RCC

Following a review of the LITESPARK-005 trial, experts on renal cell carcinoma discuss the potential role of belzutifan in the treatment algorithm.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME